extraskeletal osteosarcoma
Conditions
Interventions
None listed
Sponsors
Nara Medical University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: We included only studies reporting 5-year disease-free survival rate after surgery alone or surgery and (neo-)adjuvant chemotherapy for localized ESOS.
Exclusion criteria
Exclusion criteria: (1) We excluded patients with distant metastases at presentation. We excluded studies that did not specify 5-year disease-free survival rate, did not have a control group, or had fewer than five patients in total. (2) Patients who underwent surgery alone for localized ESOS and received chemotherapy for distant metastases that developed during the course of the disease were classified into the surgery alone group. (3) Only literature in English, Italian, and Japanese was included, and the year of publication was not restricted. Only human studies were included and animal studies were excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 5-year disease-free survival rate | — |
Countries
Japan,Europe
Contacts
Public ContactShinji Tsukamoto
Nara Medical University Department of Orthopaedic Surgery
Outcome results
None listed